Literature DB >> 18080175

Building an understanding of cystic fibrosis on the foundation of ABC transporter structures.

Juan L Mendoza1, Philip J Thomas.   

Abstract

Cystic fibrosis (CF) is a fatal disease affecting the lungs and digestive system by impairment of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). While over 1000 mutations in CFTR have been associated with CF, the majority of cases are linked to the deletion of phenylalanine 508 (delta F508). F508 is located in the first nucleotide binding domain (NBD1) of CFTR. This mutation is sufficient to impair the trafficking of CFTR to the plasma membrane and, thus, its function. As an ABC transporter, recent structural data from the family provide a framework on which to consider the effect of the delta F508 mutation on CFTR. There are fifty-seven known structures of ABC transporters and domains thereof. Only six of these structures are of the intact transporters. In addition, modern bioinformatic tools provide a wealth of sequence and structural information on the family. We will review the structural information from the RCSB structure repository and sequence databases of the ABC transporters. The available structural information was used to construct a model for CFTR based on the ABC transporter homologue, Sav1866, and provide a context for understanding the molecular pathology of Cystic Fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080175     DOI: 10.1007/s10863-007-9117-7

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  45 in total

Review 1.  ABC transporter architecture and regulatory roles of accessory domains.

Authors:  Esther Biemans-Oldehinkel; Mark K Doeven; Bert Poolman
Journal:  FEBS Lett       Date:  2005-12-12       Impact factor: 4.124

2.  Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.

Authors:  J L Teem; H A Berger; L S Ostedgaard; D P Rich; L C Tsui; M J Welsh
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

Review 3.  Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters.

Authors:  E M Leslie; R G Deeley; S P Cole
Journal:  Toxicology       Date:  2001-10-05       Impact factor: 4.221

4.  The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism.

Authors:  Kaspar P Locher; Allen T Lee; Douglas C Rees
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

5.  Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity.

Authors:  F S Seibert; P Linsdell; T W Loo; J W Hanrahan; J R Riordan; D M Clarke
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

6.  Crystal structure of the ATP-binding subunit of an ABC transporter.

Authors:  L W Hung; I X Wang; K Nikaido; P Q Liu; G F Ames; S H Kim
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

7.  The structure of the E. coli recA protein monomer and polymer.

Authors:  R M Story; I T Weber; T A Steitz
Journal:  Nature       Date:  1992-01-23       Impact factor: 49.962

8.  ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer.

Authors:  Paul C Smith; Nathan Karpowich; Linda Millen; Jonathan E Moody; Jane Rosen; Philip J Thomas; John F Hunt
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

Review 9.  Structure and mechanism of ABC transporters.

Authors:  Lutz Schmitt; Robert Tampé
Journal:  Curr Opin Struct Biol       Date:  2002-12       Impact factor: 6.809

10.  Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.

Authors:  J E Walker; M Saraste; M J Runswick; N J Gay
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  26 in total

1.  Cystic fibrosis transmembrane regulator missing the first four transmembrane segments increases wild type and DeltaF508 processing.

Authors:  Liudmila Cebotaru; Neeraj Vij; Igor Ciobanu; Jerry Wright; Terence Flotte; William B Guggino
Journal:  J Biol Chem       Date:  2008-05-28       Impact factor: 5.157

2.  Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences.

Authors:  Juan L Mendoza; André Schmidt; Qin Li; Emmanuel Nuvaga; Tyler Barrett; Robert J Bridges; Andrew P Feranchak; Chad A Brautigam; Philip J Thomas
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

Review 3.  Cystic fibrosis genetics: from molecular understanding to clinical application.

Authors:  Garry R Cutting
Journal:  Nat Rev Genet       Date:  2014-11-18       Impact factor: 53.242

Review 4.  Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas.

Authors:  Weiqiang Zhang; Naoaki Fujii; Anjaparavanda P Naren
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

Review 5.  The gating of the CFTR channel.

Authors:  Oscar Moran
Journal:  Cell Mol Life Sci       Date:  2016-10-01       Impact factor: 9.261

Review 6.  Review. Structure and mechanism of ATP-binding cassette transporters.

Authors:  Kaspar P Locher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

7.  The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain.

Authors:  Hanneke Hoelen; Bertrand Kleizen; Andre Schmidt; John Richardson; Paraskevi Charitou; Philip J Thomas; Ineke Braakman
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

8.  Mechanisms for rescue of correctable folding defects in CFTRDelta F508.

Authors:  Diane E Grove; Meredith F N Rosser; Hong Yu Ren; Anjaparavanda P Naren; Douglas M Cyr
Journal:  Mol Biol Cell       Date:  2009-07-22       Impact factor: 4.138

9.  Mutation-specific potency and efficacy of cystic fibrosis transmembrane conductance regulator chloride channel potentiators.

Authors:  Antonella Caputo; Alexandre Hinzpeter; Emanuela Caci; Nicoletta Pedemonte; Nicole Arous; Marco Di Duca; Olga Zegarra-Moran; Pascale Fanen; Luis J V Galietta
Journal:  J Pharmacol Exp Ther       Date:  2009-06-02       Impact factor: 4.030

10.  NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR.

Authors:  Voula Kanelis; Rhea P Hudson; Patrick H Thibodeau; Philip J Thomas; Julie D Forman-Kay
Journal:  EMBO J       Date:  2009-11-19       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.